Oxidative stress and inflammation in hyperglycemic crises and resolution with insulin: Implications for the acute and chronic complications of hyperglycemia

Journal of Diabetes and its Complications

Volumn 26, Issue 4, 2012, Pages 257-258

  Chaudhuri, Ajay ^a   Umpierrez, Guillermo E ^b  

^a UNIVERSITY AT BUFFALO   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GLUCOSE; INSULIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MALONALDEHYDE; PROSTAGLANDIN F2 ALPHA; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; TRANSCRIPTION FACTOR MAFA; TRANSCRIPTION FACTOR PDX 1; TUMOR NECROSIS FACTOR ALPHA;

ACUTE DISEASE; CARDIOVASCULAR RISK; CELL SURVIVAL; CHRONIC DISEASE; DIABETES MELLITUS; DIABETIC KETOACIDOSIS; EDITORIAL; GLUCOSE TRANSPORT; HEART INFARCTION; HEART SURGERY; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INFLAMMATION; INSULIN DEFICIENCY; INSULIN TREATMENT; LIPID PEROXIDATION; LIPOLYSIS; LOW DRUG DOSE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STROKE;

ACUTE DISEASE; CHRONIC DISEASE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INFLAMMATION; INSULIN; OXIDATIVE STRESS;

EID: 84863774658     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2012.04.016     Document Type: Editorial

References (19)

1. Aljada, A., Ghanim, H., Mohanty, P., Kapur, N., & Dandona, P. (2002). Insulin inhibits the pro-inflammatory transcription factor early growth response gene-1 (Egr)-1 expression in mononuclear cells (MNC) and reduces plasma tissue factor (TF) and plasminogen activator inhibitor-1 (PAI-1) concentrations. Journal of Clinical Endocrinology and Metabolism, 87, 1419-1422. (Pubitemid 36121118)
2. Brownlee, M. (2001). Biochemistry and molecular cell biology of diabetic complications. Nature, 414, 813-820.
3. Dandona, P., Chaudhuri, A., Ghanim, H., & Mohanty, P. (2009). Insulin as an antiinflammatory and antiatherogenic modulator. Journal of the American College of Cardiology, 53, S14-S20.
4. Davis, S. N., & Umpierrez, G. E. (2007). Diabetic ketoacidosis in type 2 diabetes mellitus-pathophysiology and clinical presentation. Nature Clinical Practice. Endocrinology &Metabolism, 3, 730-731. (Pubitemid 47622599)
5. Desouza, C. V., Bolli, G. B., & Fonseca, V. (2010). Hypoglycemia, diabetes, and cardiovascular events. Diabetes Care, 33, 1389-1394.
6. Ghanim, H., Mohanty, P., Deopurkar, R., Sia, C. L., Korzeniewski, K., Abuaysheh, S., et al. (2008). Acute modulation of toll-like receptors by insulin. Diabetes Care, 31, 1827-1831.
7. Harmon, J. S., Stein, R., & Robertson, R. P. (2005). Oxidative stress-mediated, post-ranslational loss of MafA protein as a contributing mechanism to loss of insulin gene expression in glucotoxic beta cells. The Journal of Biological Chemistry, 280, 11107-11113. (Pubitemid 40418415)
8. Hoffman, W. H., Burek, C. L., Waller, J. L., Fisher, L. E., Khichi, M., & Mellick, L. B. (2003). Cytokine response to diabetic ketoacidosis and its treatment. Clinical Immunology, 108, 175-181. (Pubitemid 37117364)
9. Karavanaki, K., Karanika, E., Georga, S., Bartzeliotou, A., Tsouvalas, M., Konstantopoulos, I., et al. (2011). Cytokine response to diabetic ketoacidosis (DKA) in children with type 1 diabetes (T1DM). Endocrine Journal, 58, 1045-1053.
10. Rains, J. L., & Jain, S. K. (2011). Oxidative stress, insulin signaling, and diabetes. Free Radical Biology & Medicine, 50, 567-575.
11. Razavi Nematollahi, L., Kitabchi, A. E., Stentz, F. B., Wan, J. Y., Larijani, B. A., Tehrani, M. M., et al. (2009). Proinflammatory cytokines in response to insulin-induced hypoglycemic stress in healthy subjects. Metabolism, 58, 443-448.
12. Sharma, A., Olson, L. K., Robertson, R. P., & Stein, R. (1995). The reduction of insulin gene transcription in HIT-T15 beta cells chronically exposed to high glucose concentration is associated with the loss of RIPE3b1 and STF-1 transcription factor expression. Molecular Endocrinology, 9, 1127-1134.
13. Shen X, Li J, Zou S, Wu H-J. The relationship between oxidative stress and the levels of serum circulating adhesion molecules in patients with hyperglycemia crises. Journal of Diabetes and Its Complications.
14. Smiley, D., & Umpierrez, G. E. (2010). Management of hyperglycemia in hospitalized patients. Annals of the New York Academy of Sciences, 1212, 1-11.
15. Stentz, F. B., Umpierrez, G. E., Cuervo, R., & Kitabchi, A. E. (2004). Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises. Diabetes, 53, 2079-2086. (Pubitemid 38970758)
16. Umpierrez, G. E. (2006). Ketosis-prone type 2 diabetes: time to revise the classification of diabetes. Diabetes Care, 29, 2755-2757.
17. Umpierrez, G. E., Isaacs, S. D., Bazargan, N., You, X., Thaler, L. M., & Kitabchi, A. E. (2002). Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. Journal of Clinical Endocrinology and Metabolism, 87, 978-982. (Pubitemid 36121050)
18. Umpierrez, G. E., Jones, S., Smiley, D., Mulligan, P., Keyler, T., Temponi, A., et al. (2009). Insulin analogs versus human insulin in the treatment of patients with diabetic ketoacidosis: a randomized controlled trial. Diabetes Care, 32, 1164-1169.
19. Vantyghem, M. C., Balduyck, M., Zerimech, F., Martin, A., Douillard, C., Bans, S., et al. (2000). Oxidative markers in diabetic ketoacidosis. Journal of Endocrinological Investigation, 23, 732-736. (Pubitemid 32041052)